MRNA: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/3ef58907-0380-4987-9976-d1963de0dfce/","filing_uuid":"3ef58907-0380-4987-9976-d1963de0dfce","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3ef58907-0380-4987-9976-d1963de0dfce/print/","filing_document_content_type":"text/html","income":null,"expenses":"70000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Unger Skelton","dt_posted":"2026-10-16T16:27:54-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"28 Liberty Ship Way","registrant_address_2":"Suite 2815","registrant_different_address":false,"registrant_city":"Sausalito","registrant_state":"CA","registrant_zip":"94965","registrant":{"id":401107958,"url":"https://lda.gov/api/v1/registrants/401107958/","house_registrant_id":56260,"name":"MODERNA, INC.","description":null,"address_1":"28 Liberty Ship Way","address_2":"Suite 2815","address_3":null,"address_4":null,"city":"Sausalito","state":"CA","state_display":"California","zip":"94965","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE U SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-07-24T13:17:58.779813-04:00"},"client":{"id":57657,"url":"https://lda.gov/api/v1/clients/57657/","client_id":57657,"name":"MODERNA, INC.","general_description":"Pharmaceuticals","client_government_entity":null,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-10-31"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Vaccine Policy, FDA Vaccine Approval, mRNA Federal Policy, Oncology Innovation, Vaccines for Children Program, Patent Litigation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151608,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"CURTIS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144626,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"LEPORE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}